Failure of intravenous immunoglobulin to arrest progression of multiple sclerosis: a clinical and MRI based study.

about

Immunotherapy of multiple sclerosis: the state of the art.

P2860

Q38083041-0E0266AB-077B-4D38-9551-4AE94C353B79

P2860

Failure of intravenous immunoglobulin to arrest progression of multiple sclerosis: a clinical and MRI based study.

Item

http://www.wikidata.org/entity/Q48516971

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年学术文章

@wuu

1997年学术文章

@zh-cn

1997年学术文章

@zh-hans

1997年学术文章

@zh-my

1997年学术文章

@zh-sg

1997年學術文章

@yue

1997年學術文章

@zh

1997年學術文章

@zh-hant

name

Failure of intravenous immunog ...... clinical and MRI based study.

@en

Failure of intravenous immunog ...... clinical and MRI based study.

@nl

type

Item

label

Failure of intravenous immunog ...... clinical and MRI based study.

@en

Failure of intravenous immunog ...... clinical and MRI based study.

@nl

prefLabel

Failure of intravenous immunog ...... clinical and MRI based study.

@en

Failure of intravenous immunog ...... clinical and MRI based study.

@nl

P1476

Failure of intravenous immunog ...... clinical and MRI based study.

@en

P2093

G S Francis

http://www.w3.org/2001/XMLSchema#string

J P Antel

http://www.w3.org/2001/XMLSchema#string

M S Freedman

http://www.w3.org/2001/XMLSchema#string

P2860

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

Acute renal failure resulting from intravenous immunoglobulin therapy.

Intravenous immunoglobulin therapy in multiple sclerosis: progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial.

Experience with intravenous immunoglobulin in myasthenia gravis: a review.

Promotion of remyelination by polyclonal immunoglobulin in Theiler's virus-induced demyelination and in multiple sclerosis.

Immunoglobulin treatment in human and experimental epilepsy

Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretion.

New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

P304

370-376

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/135245859700300602

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1997-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9493636

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

Failure of intravenous immunoglobulin to arrest progression of multiple sclerosis: a clinical and MRI based study.

about

P2860

P2860

Failure of intravenous immunoglobulin to arrest progression of multiple sclerosis: a clinical and MRI based study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921